https://ashpublications.org/blood/article-abstract/doi/10.1182/blood.2024024968/518024/Ex-Vivo-Venetoclax-Sensitivity-Predicts-Clinical?redirectedFrom=fulltext

Props to the Finnish team for the amazing idea to assess the ex vivo sensitivity of Ven in AML patients, both de novo and relapsed. This approach can be quickly integrated to all large hospitals' labs and inform the best tx approach for elderly AML patients!